Hydromorphone is a pure opioid, a semi-synthetic hydrogenated ketone derivative of morphine that has been available clinically since 1920. Structurally, hydromorphone derived from morphine in the modification of the hydroxyl group in the carbon 6 to a carbonyl and the absence of a double bond between the carbon 7 and 8. Due to these modifications, it present...
Hydromorphone is indicated for the management of moderate to severe acute pain and severe chronic pain. Due to its addictive potential and overdose risk, hydromorphone is only prescribed when other first-line treatments have failed.
...
University of Texas Southwestern Medical Center, Dallas, Texas, United States
University of Maryland, Baltimore, Maryland, United States
Henry Ford Health System, Detroit, Michigan, United States
NorthShore University HealthSystem, Evanston, Illinois, United States
Lotus Clinical Research, LLC, Pasadena, California, United States
Children's Hospital of Winnipeg, Winnipeg, Manitoba, Canada
Stollery Children's Hospital Emergency Department, Edmonton, Alberta, Canada
Alberta Children's Hospital, Calgary, Alberta, Canada
Duke University Medical Center, Durham, North Carolina, United States
The second affiliated hospital of Zhejiang University, Hangzhou, Zhejiang, China
M D Anderson Cancer Center, Houston, Texas, United States
Montefiore Medical Center, Bronx, New York, United States
Mount Sinai Hospital, Toronto, Ontario, Canada
Baylor College of Medicine, Houston, Texas, United States
Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.